232 related articles for article (PubMed ID: 16328385)
21. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
22. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.
Okita R; Yamaguchi Y; Ohara M; Hironaka K; Okawaki M; Nagamine I; Ikeda T; Emi A; Hihara J; Okada M
Int J Oncol; 2009 Feb; 34(2):563-72. PubMed ID: 19148493
[TBL] [Abstract][Full Text] [Related]
23. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
Liu L; Wu G; Yao JX; Ding Q; Huang SA
Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
[TBL] [Abstract][Full Text] [Related]
24. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.
Akagi J; Baba H
Int J Clin Oncol; 2008 Dec; 13(6):528-35. PubMed ID: 19093181
[TBL] [Abstract][Full Text] [Related]
26. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
27. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.
Miller AM; Lundberg K; Ozenci V; Banham AH; Hellström M; Egevad L; Pisa P
J Immunol; 2006 Nov; 177(10):7398-405. PubMed ID: 17082659
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
29. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
30. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.
Lundgren A; Strömberg E; Sjöling A; Lindholm C; Enarsson K; Edebo A; Johnsson E; Suri-Payer E; Larsson P; Rudin A; Svennerholm AM; Lundin BS
Infect Immun; 2005 Jan; 73(1):523-31. PubMed ID: 15618192
[TBL] [Abstract][Full Text] [Related]
31. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.
Clark FJ; Gregg R; Piper K; Dunnion D; Freeman L; Griffiths M; Begum G; Mahendra P; Craddock C; Moss P; Chakraverty R
Blood; 2004 Mar; 103(6):2410-6. PubMed ID: 14604970
[TBL] [Abstract][Full Text] [Related]
32. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.
Suárez A; López P; Gómez J; Gutiérrez C
Ann Rheum Dis; 2006 Nov; 65(11):1512-7. PubMed ID: 16606650
[TBL] [Abstract][Full Text] [Related]
33. Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome.
Zhu LY; Chi LJ; Wang X; Zhou H
Clin Exp Immunol; 2009 Apr; 156(1):88-96. PubMed ID: 19210520
[TBL] [Abstract][Full Text] [Related]
34. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
35. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors.
Haghshenas MR; Khademi B; Faghih Z; Ghaderi A; Erfani N
Immunol Lett; 2015 Apr; 164(2):109-16. PubMed ID: 25739075
[TBL] [Abstract][Full Text] [Related]
36. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
37. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
38. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
[TBL] [Abstract][Full Text] [Related]
39. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
Gabitass RF; Annels NE; Stocken DD; Pandha HA; Middleton GW
Cancer Immunol Immunother; 2011 Oct; 60(10):1419-30. PubMed ID: 21644036
[TBL] [Abstract][Full Text] [Related]
40. Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy.
Wang WH; Xu HY; Zhao ZM; Zhang GM; Lin FW
Int Immunopharmacol; 2018 Dec; 65():279-283. PubMed ID: 30342344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
